Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 1996 | 1997 | 1998 | 1999 | |
|---|---|---|---|---|
| Revenue | $11.7M | $27.3M | $47.4M | $62.8M |
| Cost of revenue | $4.6M | $12.2M | $21.3M | $24.1M |
| Gross profit | $7.1M | $15.1M | $26.1M | $38.7M |
| Gross margin | 60.7% | 55.3% | 55.1% | 61.6% |
| R&D | $0 | $0 | $0 | $0 |
| Operating income | $1.8M | $3.2M | $7.1M | $12.4M |
| EBITDA | $2.8M | $5.4M | $11.1M | $18.3M |
| Net income | $800.0K | $1.3M | $1.2M | −$10.9M |
| Net margin | 6.8% | 4.8% | 2.5% | -17.4% |
| EPS (diluted) | 18.06 | 23.88 | 17.48 | -122.33 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds BEEN.
No tracked institution reports a position in BEEN as of their last filing.
No one on the platform has traded BEEN yet.
| +0.00% |
| $43750 |
| — |
| BIMOBioNeutra International, Ltd. | $0.00 | +0.00% | $16343 | — |
| BRDSQBird Global, Inc. | $0.00 | +900.00% | $15815 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.